Briefly, we treated available HCC lines (BEL7402, HepG2, Huh7, Hep3B, and SMMC7721) with a range of doses of soluble TRAIL for a 96 h period revealing variable TRAIL sensitivity among these cell lines (Fig. 1a). Here, TNFSF10 is linked to hepatocellular carcinoma.